Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Study: Chemotherapy drugs may promote muscle mitochondrial dysfunction

Study: Chemotherapy drugs may promote muscle mitochondrial dysfunction

Combination approach appears to improve chemotherapy response, boost anti-tumor immunity

Combination approach appears to improve chemotherapy response, boost anti-tumor immunity

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

'Plastic antibodies' effectively target and eliminate tumor cells

'Plastic antibodies' effectively target and eliminate tumor cells

Innovative platform developed to destroy cancer cells

Innovative platform developed to destroy cancer cells

New drug delivery system delivers anticancer drugs that reduce tumor size

New drug delivery system delivers anticancer drugs that reduce tumor size

Doxorubicin drug causes heart toxicity by disrupting the immune system

Doxorubicin drug causes heart toxicity by disrupting the immune system

European Commission approves Pfizer’s first oncology biosimilar

European Commission approves Pfizer’s first oncology biosimilar

New technique measures how well cancer drugs reach their targets

New technique measures how well cancer drugs reach their targets

A small molecule can inhibit chemotherapy resistance of certain tumors

A small molecule can inhibit chemotherapy resistance of certain tumors

Researchers establish versatile, powerful model to analyze human cancer

Researchers establish versatile, powerful model to analyze human cancer

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

Study shows new approach to improve survival rates for patients with stage IV Wilms tumors

Study shows new approach to improve survival rates for patients with stage IV Wilms tumors